Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Why is dulera so expensive?Teriflunomide brand name?What company makes livalo?Dulera combination inhaler market position?Dulera coupons discounts?
See the DrugPatentWatch profile for aranesp
Aranesp injection is used to treat anemia (low red blood cell levels) in certain people. Depending on the patient’s situation, it’s prescribed to help raise hemoglobin and reduce the need for blood transfusions. It is commonly used for anemia related to: - Chronic kidney disease (CKD) - Cancer treatment (chemotherapy-induced anemia) in some patients - Treatment of anemia in some people receiving certain types of intensive therapy, as determined by the prescriber
Aranesp contains darbepoetin alfa, a man-made version of erythropoietin, a hormone that helps the body make red blood cells. By boosting red blood cell production, Aranesp helps increase hemoglobin levels in people whose anemia is linked to low erythropoietin activity or suppressed red blood cell production.
Aranesp is prescribed with attention to hemoglobin targets and dosing, because too-high hemoglobin levels or using it in the wrong setting can increase the risk of serious cardiovascular events and blood clots. It is typically monitored through regular blood tests.
For a quick check of branded indication language and patent/drug-status context, you can also review listings for Aranesp on DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Aranesp :